Consensus Novo Nordisk A/S Nyse

Equities

NVO

US6701002056

Real-time Estimate Cboe BZX Other stock markets 15:55:40 2024-05-03 EDT			5-day change	1st Jan Change
123.3 ^USD	-0.57%		-2.76%	+19.24%

09:16pm	News Highlights : Top Company News of the Day - Friday at 3 PM ET	DJ
07:15pm	News Highlights : Top Company News of the Day - Friday at 1 PM ET	DJ

Evolution of the average Target Price on Novo Nordisk A/S

Price target over the last 5 years

History of analyst recommendation changes

1da99d435afe2b118f49a93.9vSjseciJZm_26wCERLsQd3R8KKN2uB2DVsmbKfXwfk.nrDlwr8PVs-Pk8JuZWSjIo6UoJbHntAYPQ9pL8qwk8qXmvHzvVdB2tGMww~b12554c1964922ad1c9fb77d9ae894e7

Analyst Recommendations on Novo Nordisk A/S

NOVO NORDISK : DZ Bank sticks Neutral	10:07am	ZD
NOVO NORDISK : Stifel lowers target slightly	09:01am	CF
NOVO NORDISK : Buy rating from Deutsche Bank	07:23am	ZD
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	06:36am	RE
NOVO NORDISK : JP Morgan gives a Buy rating	02:32am	ZD
NOVO NORDISK : Q1 beat; guidance upgrade but sentiment nonetheless dampened by price reductions	05-02
NOVO NORDISK : Gets a Buy rating from Barclays	05-02	ZD
NOVO NORDISK : UBS gives a Neutral rating	05-02	ZD
NOVO NORDISK : JP Morgan gives a Buy rating	05-02	ZD
NOVO NORDISK : Receives a Sell rating from Jefferies	05-02	ZD
NOVO NORDISK : UBS sticks Neutral	04-29	ZD
NOVO NORDISK : JP Morgan gives a Buy rating	04-25	ZD
NOVO NORDISK : Bernstein maintains a Buy rating	04-24	ZD
BMO Capital Starts Novo Nordisk With Outperform Rating, $163 Price Target	04-12	MT
NOVO NORDISK : UBS sticks Neutral	03-26	ZD
NOVO NORDISK : Barclays maintains a Buy rating	03-25	ZD
NOVO NORDISK : Berenberg remains Neutral	03-18	ZD
NOVO NORDISK : Novo’s bag is full of pearls!	03-15
NOVO NORDISK : Barclays reiterates its Buy rating	03-11	ZD
NOVO NORDISK : UBS sticks Neutral	03-11	ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating	03-08	ZD
NOVO NORDISK : Deutsche Bank reiterates its Buy rating	03-08	ZD
NOVO NORDISK : Novo’s got a strong arsenal to go the distance	03-08
NOVO NORDISK : Buy rating from Barclays	03-07	ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank	03-06	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

873.1 DKK

Average target price

908.8 DKK

Spread / Average Target

+4.09%

High Price Target

1,120 DKK

Spread / Highest target

+28.28%

Low Price Target

530 DKK

Spread / Lowest Target

-39.30%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Novo Nordisk A/S

DZ BANK	Elmar Kraus
alphavalue	Abhishek Raval
JEFFERIES	Peter Welford
JPMORGAN	Richard Vosser
UBS	Jo Walton
BARCLAYS	Emily Field
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
BERNSTEIN RESEARCH	Florent Cespedes
BMO Capital
BERENBERG	Kerry Holford
Cantor Fitzgerald
TD Cowen
Stifel Nicolaus
ODDO BHF
Berenberg Bank
CREDIT SUISSE	Lorenzo Biasio
GOLDMAN SACHS	Keyur Parekh
Morgan Stanley
BNP Paribas Exane
JPMorgan Chase
Guggenheim
Bryan, Garnier & Co.
Deutsche Bank Securities
DEUTSCHE BANK	Emmanuel Papadakis
Liberum Capital
KEPLER CHEUVREUX	David Evans
HSBC	Stephen McGarry
INDEPENDENT RESEARCH	Tobias Gottschalt
BANK OF AMERICA (BOFA)	Sachin Jain

Ratings for Novo Nordisk A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar